Article Sidebar

pdf
Date Published: 10/06/2024
Abstract Views: 51
Views pdf: 32
DOI: https://doi.org/10.51298/vmj.v539i2.9822
Issue
Vol. 539 No. 2 (2024)
Section
Các bài báo
How to Cite
Lê, V. P., Nguyễn, X. K., Phạm, V. V., & Hoàng, Đình A. (2024). STUDYING LIVER FIBROSCAN ULTRASOUND IMAGING CHARACTERISTICS IN PATIENTS WITH TYPE 2 DIABETES TYPE 2 DIABETES. Vietnam Medical Journal, 539(2). https://doi.org/10.51298/vmj.v539i2.9822

STUDYING LIVER FIBROSCAN ULTRASOUND IMAGING CHARACTERISTICS IN PATIENTS WITH TYPE 2 DIABETES TYPE 2 DIABETES

Văn Phúc Lê, Xuân Khái Nguyễn, Văn Việt Phạm, Đình Anh Hoàng

Main Article Content

Abstract

Objective: To describe the characteristics of liver fibroscan ultrasound images in patients with type 2 diabetes. Subjects and methods: Cross-sectional and prospective description of 142 type 2 diabetes patients undergoing Fibroscan ultrasound at Military Hospital 103 from April 2023 to February 2024. Results: The average fatty liver index on Fibroscan was 250.2 ± 63.8 dB/m. Most patients have grade S3 fatty liver on Fibroscan (28.9%). There is no difference between the degree of fatty liver on Fibroscan and the duration of type 2 diabetes. The average liver fibrosis index on Fibroscan is 6.16 ± 3.1 kPa. Most patients have grade F1 fibrosis on Fibroscan (14.1%). There was no difference in the average liver fibrosis index over time. Conclusion: The average fatty liver index on Fibroscan was 250.2 ± 63.8 dB/m. Most patients have grade S3 fatty liver on Fibroscan (28.9%). The average liver fibrosis index on Fibroscan was 6.16 ± 3.1 kPa. Most patients have grade F1 fibrosis on Fibroscan (14.1%). Duration of type 2 diabetes does not affect the degree of fatty liver and fibrosis on Fibroscan.

Article Details

Keywords

: Fatty liver, Liver fibrosis, Fibroscan.

References

1. Tapper Elliot B, Castera Laurent, Afdhal Nezam H. "FibroScan (vibration-controlled transient elastography): where does it stand in the United States practice", Clinical Gastroenterology Hepatology. 2015; 13(1), pp. 27-36.
2. Wong Vincent Wai‐Sun, Vergniol Julien, Wong Grace Lai‐Hung et al. (2010), "Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease", Hepatology, 51(2), pp. 454-462.
3. Sasso Magali, Beaugrand Michel, De Ledinghen Victor et al. (2010), "Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes", Ultrasound in medicine & biology, 36(11), pp. 1825-1835.
4. Kwok Raymond, Choi Kai Chow, Wong Grace Lai-Hung et al. "Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study", Gut. 2015;pp. 2015-309265.
5. Trần Thị Khánh Tường, Phạm Quang Thiên Phú. "Mối tương quan giữa mức độ nhiễm mỡ gan và xơ hóa gan ở bệnh nhân đái tháo đường típ 2 bị bệnh gan nhiễm mỡ không do rượu", Tạp chí y học Việt Nam. 2020; 488(1), pp. 21 - 25.
6. Asero C., Giandalia A., Cacciola I. et al. (2023), "High Prevalence of Severe Hepatic Fibrosis in Type 2 Diabetic Outpatients Screened for Non-Alcoholic Fatty Liver Disease", J Clin Med, 12(8).
7. Lomonaco Romina, Godinez Leiva Eddison, Bril Fernando et al. (2021), "Advanced liver fibrosis is common in patients with type 2 diabetes followed in the outpatient setting: the need for systematic screening", Diabetes Care, 44(2), pp. 399-406.